Glycosylation changes associated with anti-PD-1/PD-L1 Treatment
Ontology highlight
ABSTRACT: To systematically characterize anti-PD-1/PD-L1 immunotherapy-related changes in serum glycoproteins and discover novel biomarkers related to treatment response, we analyzed a series of sera samples from patients with metastatic lung squamous cell carcinoma (SCC) and lung adenocarcinoma (ADC), collected before and during ICIs treatment, with mass-spectrometry-based label-free quantification methodology.
ORGANISM(S): Homo Sapiens
SUBMITTER: Haojie Lu
PROVIDER: PXD039141 | iProX | Sat Dec 31 00:00:00 GMT 2022
REPOSITORIES: iProX
ACCESS DATA